Literature DB >> 11742865

Activation of p38 mitogen-activated protein kinases by endothelin and noradrenaline in small arteries, regulation by calcium influx and tyrosine kinases, and their role in contraction.

J Ohanian1, P Cunliffe, E Ceppi, A Alder, E Heerkens, V Ohanian.   

Abstract

Small-artery responses to vasoconstrictor agonists are important for vascular function. To investigate the signaling pathways involved in contraction, we studied the activation and regulation of p38 mitogen-activated protein kinases (p38MAPKs) and heat shock protein (HSP) kinase by endothelin and noradrenaline in rat mesenteric arteries. Both vasoconstrictors activated p38alpha and/or p38beta but not p38gamma or p38delta, leading to increased HSP kinase activity. p38MAPK activation by noradrenaline was maximum between 2 and 10 minutes and was wholly dependent on calcium influx but insensitive to the tyrosine kinase inhibitor herbimycin A. In contrast, endothelin induced a biphasic response, with activation at 2 and 10 minutes. The early activity was wholly dependent on calcium influx and inhibited by herbimycin A. The later activity was only 50% calcium dependent, was insensitive to herbimycin A, but was 50% inhibited by genistein, a nonselective tyrosine kinase inhibitor. With both agonists, p38MAPK activity returned to basal by 30 minutes. SB203580, a p38MAPK inhibitor, blocked agonist-induced HSP kinase activity, and herbimycin A inhibited activation by endothelin but not by noradrenaline. In addition, SB203580 inhibited noradrenaline-induced contraction but had little effect on contraction to endothelin. These data show that vasoconstrictors use different upstream activators of p38MAPK in vascular tissue and that the p38MAPK pathway is selectively implicated in the contractile response to noradrenaline in small arteries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742865     DOI: 10.1161/hq1201.100264

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  A mechanism converting psychosocial stress into mononuclear cell activation.

Authors:  Angelika Bierhaus; Jutta Wolf; Martin Andrassy; Nicolas Rohleder; Per M Humpert; Dimitri Petrov; Roman Ferstl; Maximilian von Eynatten; Thoralf Wendt; Gottfried Rudofsky; Martina Joswig; Michael Morcos; Markus Schwaninger; Bruce McEwen; Clemens Kirschbaum; Peter P Nawroth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

Review 2.  Non-receptor tyrosine kinases and the actin cytoskeleton in contractile vascular smooth muscle.

Authors:  Jacqueline Ohanian; Maria Pieri; Vasken Ohanian
Journal:  J Physiol       Date:  2014-12-23       Impact factor: 5.182

3.  Pregnancy reduces RhoA/Rho kinase and protein kinase C signaling pathways downstream of thromboxane receptor activation in the rat uterine artery.

Authors:  Styliani Goulopoulou; Johanna L Hannan; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

4.  PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis.

Authors:  Shun-Hsin Liang; Wei Zhang; Barbara C McGrath; Peichuan Zhang; Douglas R Cavener
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

5.  Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation.

Authors:  A B El-Remessy; Y Tang; G Zhu; S Matragoon; Y Khalifa; E K Liu; J-Y Liu; E Hanson; S Mian; N Fatteh; G I Liou
Journal:  Mol Vis       Date:  2008-12-03       Impact factor: 2.367

6.  Neflamapimod induces vasodilation in resistance mesenteric arteries by inhibiting p38 MAPKα and downstream Hsp27 phosphorylation.

Authors:  Ajay K Pandey; Farzana Zerin; Sreelakshmi N Menon; Tanzia I Tithi; Khue P Nguyen; Tran Vo; Morgan L Daniel; Sherif Hafez; Md Ashraful Alam; Raquibul Hasan
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.